RT @Age_and_Ageing: Suzy Hope speaking to the diabetes session at #eugms2022 this morning. Author of: Random non-fasting C-peptide testing…
RT @Age_and_Ageing: Suzy Hope speaking to the diabetes session at #eugms2022 this morning. Author of: Random non-fasting C-peptide testing…
Suzy Hope speaking to the diabetes session at #eugms2022 this morning. Author of: Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia https://t.co/8ZN9afXMDQ @DiabetologiaJnl
@DrKathOwen @parthaskar @WilmotEmma @kamleshkhunti @JDRFUK @DiabetesUK @ABCDiab @AliRacaniere @AmarPut @drpatrickholmes @athattersley @docwas @drfrasergibb Only valuable if < 600 - which increases risk of hypoglyceamia. https://t.co/nWU92CbVwK
RT @DipeshGopal: Great talk from Andrew Hattersley about diagnosing type 1 diabetes in adults > age 30 - we should be doing⬆C-peptide testi…
Great talk from Andrew Hattersley about diagnosing type 1 diabetes in adults > age 30 - we should be doing⬆C-peptide testing @bmj_latest 🔗: https://t.co/2WCSrtPuaP MODY risk calc: https://t.co/oIDuEqgWER @DiabetologiaJnl 🔗: https://t.co/yj1xxQ9i8f
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia | SpringerLink https://t.co/ISzIu1LCUS
@WilmotEmma @RAOram @bionictype1 @dr_annarachel @Edinburgh_Endo @athattersley https://t.co/FYUOc8VVdD also that random C-peptide predicts risk of hypoglycaemia in T2 @athattersley
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant des hypoglycémies (OR = 2,0, p<0,001) ou des hypoglycémies sévères (OR = 5,0, p<0,001) dans une cohorte de 2
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant des hypoglycémies (OR = 2,0, p<0,001) ou des hypoglycémies sévères (OR = 5,0, p<0,001) dans une cohorte de 2
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant des hypoglycémies (OR = 2,0, p<0,001) ou des hypoglycémies sévères (OR = 5,0, p<0,001) dans une cohorte de 2
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
RT @SFDiabete: Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant…
Un dosage de peptide C non à jeun pourrait, s’il est <200 pmol/L, identifier les sujets DT2 traités par insuline rapportant des hypoglycémies (OR = 2,0, p<0,001) ou des hypoglycémies sévères (OR = 5,0, p<0,001) dans une cohorte de 256 sujets #dia
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypoglycaemia https://t.co/fXSEh5LRca 🔓
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @glycogentheory: C-peptide is also a good way to determine if patients with type 2 diabetes can come off insulin using LCHF. If low may…
RT @glycogentheory: C-peptide is also a good way to determine if patients with type 2 diabetes can come off insulin using LCHF. If low may…
C-peptide is also a good way to determine if patients with type 2 diabetes can come off insulin using LCHF. If low may still require basal insulin. Otherwise can have them off insulin in a couple of weeks. Medical supervision is mandatory to prevent hypos!
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypoglycaemia https://t.co/fXSEh5ugkC 🔓
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @SVH00: Simple blood test can help identify ppl with #type2diabetes at higher risk of #hypoglycaemia @ExeterMed @DocStrain @drpratikc ht…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
Cペプチドの複数回測定を外来診療でも行いたいとこです。Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia #springerlink https://t.co/3E02gf8031
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
RT @SVH00: Simple blood test can help identify ppl with #type2diabetes at higher risk of #hypoglycaemia @ExeterMed @DocStrain @drpratikc ht…
RT @athattersley: Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial informa…
Not all insulin treated Type 2 is the same! A simple £7 random C peptide measurement done in clinic gives crucial information on hypoglycaemia risk in insulin treated type 2 . Lovely paper from @SVH00 @angusgjones @ExeterMed https://t.co/76eJGmzoZj
RT @SVH00: Simple blood test can help identify ppl with #type2diabetes at higher risk of #hypoglycaemia @ExeterMed @DocStrain @drpratikc ht…
Simple blood test can help identify ppl with #type2diabetes at higher risk of #hypoglycaemia @ExeterMed @DocStrain @drpratikc https://t.co/x7JT2oEuUl
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
RT @DiabetologiaJnl: Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypogl…
Random non-fasting C-peptide testing can identify patients with insulin-treated #type2diabetes at high risk of #hypoglycaemia https://t.co/fXSEh5ugkC 🔓
RT @SVH00: Exciting stuff! This could help identify those people with insulin-treated #type2diabetes at highest risk of hypos.... @GeriSoc…
RT @DocStrain: Another step towards personalised care. Single cheap test predicts those at highest risk of hypos. https://t.co/twgztJq0rW
RT @DocStrain: Another step towards personalised care. Single cheap test predicts those at highest risk of hypos. https://t.co/twgztJq0rW
Exciting stuff! This could help identify those people with insulin-treated #type2diabetes at highest risk of hypos.... @GeriSoc https://t.co/whgdbziYg3
Thanks Pratik! Random c-peptide predicts hypo risk in insulin-treated type 2 diabetes... #diabetes @ExeterMed #hypoglycemia https://t.co/KILHaMRUCy
Another step towards personalised care. Single cheap test predicts those at highest risk of hypos. https://t.co/twgztJq0rW
Can non-fasting C-peptide measurement be used to assess hypoglycaemia risk in diabetes? https://t.co/bFWt2G2MOr #healthstats @bshieldsexeter
RT @drpratikc: Random c peptide predicts hypo risk - lovely work from Exeter, gr8 2 b involved @ABCDiab @youngdiab @DiabetesKings https://t…
Random c peptide predicts hypo risk - lovely work from Exeter, gr8 2 b involved @ABCDiab @youngdiab @DiabetesKings https://t.co/JFiGiUl5Qn
RT @SVH00: Hypo awareness week - recognising insulin-treated people with type 2 diabetes at high risk, https://t.co/2n4aqNUs6l #diabetes @E…
Hypo awareness week - recognising insulin-treated people with type 2 diabetes at high risk, https://t.co/2n4aqNUs6l #diabetes @ExeterMed